ArticleEpilepsy & behavior reports2026
Subcortical band heterotopia in a child with new-onset seizures: A case report.
Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subcortical band heterotopia (SBH), also known as "double cortex" syndrome, is a rare neuronal migration disorder characterized by symmetric bands of heterotopic gray matter located between the cerebral cortex and lateral ventricles. It predominantly affects females and typically presents in childhood or adolescence with epilepsy and variable cognitive or motor impairment. We report a 9-year-old girl with normal antenatal, perinatal, developmental, and academic history who presented with a one‑month history of frequent generalized tonic-clonic seizures accompanied by new onset generalized limb weakness. Neurological examination revealed mild, symmetric weakness with brisk deep tendon reflexes but preserved cranial nerve and sensory function. Routine laboratory tests and electroencephalography were unremarkable. Brain magnetic resonance imaging demonstrated classic features of SBH, including bilateral, well-defined bands of gray matter deep to and paralleling the cortical surface, separated from the overlying cortex by intervening white matter and isointense to normal cortex on all sequences. A diagnosis of SBH was made based on these characteristic imaging findings. The patient was started on phenytoin, reflecting local prescribing practices and formulary availability in resource‑limited settings, resulting in effective seizure control and clinical stability on follow‑up; genetic testing for DCX or other implicated genes was not performed due to resource limitations. This case highlights that SBH can present in a developmentally normal child with new-onset generalized seizures and limb weakness, underscores the crucial role of MRI in diagnosis where genetic testing is unavailable, and emphasizes the importance of early recognition and tailored antiepileptic therapy to optimize long‑term neurological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.